Click here to read the Cover Story, “Technology, education key to changing presbyopia treatment paradigm.” When patients come to my office for comprehensive eye exams, common questions ...

Please provide your email address to receive an email when new articles are posted on . Few conditions impact as many people worldwide as presbyopia. Recent estimates have placed the prevalence of ...

Presbyopia is caused by a stiffening in the lens of the eye that develops in people after the age of 40, and affects an estimated 128 million people in the US. AbbVie is recommending Vuity ...

LENZ Therapeutics (formerly Presbyopia Therapies) is working on eyedrops containing aceclidine – thought to act like pilocarpine as a miotic agent, reducing eye pressure – showed improvements ...

The model used to summarize this release may make ... aceclidine-based eye drop to improve near vision in patients with presbyopia. LENZ’s product candidate LNZ100 is a preservative-free ...